Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults

NCT06279871 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1514

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: ARCT-2303
BIOLOGICAL: Influenza vaccine
BIOLOGICAL: Influenza vaccine, adjuvanted
OTHER: Placebo

Sponsor

Arcturus Therapeutics, Inc.

Collaborators

[object Object]
[object Object]